Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • U vs GSK✓SelectedUSD · GSKU vs GSK performance historyLatest closeAs of+5.24%11/13
Stock and ETF performance explorer

U vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-73.3%
GSK return
+44.4%
Excess return
-117.7%
Maximum drawdown
-93.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+5.2%+0.5%+4.7%+5.2%
7D+2.6%+1.1%+1.4%+2.5%
30D+27.6%+6.3%+21.2%+26.8%
3M+15.3%+1.8%+13.5%+15.1%
6M+96.4%+1.7%+94.7%+95.8%
YTD+19.6%+6.5%+13.0%+16.9%
1Y+42.1%+9.5%+32.6%+38.1%
3Y+87.5%+65.3%+22.2%+58.0%
All-73.3%+44.4%-117.7%-77.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling